BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3513293)

  • 1. Acid secretory tests in peptic ulcer disease before and after parietal cell vagotomy.
    Graffner H; Liedberg G; Oscarson J
    Scand J Gastroenterol; 1986 Jan; 21(1):41-6. PubMed ID: 3513293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proximal gastric vagotomy for peptic ulcer disease: follow-up of 483 patients for 3 to 14 years.
    Valen B; Dregelid E; Tønder B; Svanes K
    Surgery; 1991 Nov; 110(5):824-31. PubMed ID: 1948651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective controlled vagotomy trial for duodenal ulcer: primary results, sequelae, acid secretion, and recurrence rates two to five years after operation.
    Christiansen J; Jensen HE; Ejby-Poulsen P; Bardram L; Henriksen FW
    Ann Surg; 1981 Jan; 193(1):49-55. PubMed ID: 7006528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parietal cell vagotomy in the surgical treatment of chronic duodenal, pyloric and prepyloric ulcer disease.
    Graffner HO; Liedberg GF; Oscarson JE
    Int Surg; 1985; 70(2):139-44. PubMed ID: 4055278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid and pepsin responses to graded doses of pentagastrin in duodenal and corporeal gastric ulcer patients before and after selective proximal vagotomy.
    Emås S; Aly A
    Am J Surg; 1985 Nov; 150(5):543-9. PubMed ID: 3933370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric acid response to sham feeding and pentagastrin before and after parietal cell vagotomy in patients with duodenal ulcer.
    Nielsen HO; Bekker C; Kronborg O; Andersen D
    Scand J Gastroenterol; 1982 Jan; 17(1):133-6. PubMed ID: 7134828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One hundred patients ten years after parietal cell vagotomy.
    Staël von Holstein C; Graffner H; Oscarson J
    Br J Surg; 1987 Feb; 74(2):101-3. PubMed ID: 3545366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified sham feeding test after parietal cell vagotomy for juxtapyloric ulcer disease in patients with and without recurrent ulcers.
    Ström M; Bodemar G; Lindhagen J; Sjödahl R; Walan A
    Scand J Gastroenterol; 1987 Apr; 22(3):279-88. PubMed ID: 3296133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence after parietal cell vagotomy for peptic ulcer disease.
    Graffner HO; Liedberg GF; Oscarson JE
    Am J Surg; 1985 Sep; 150(3):336-40. PubMed ID: 4037193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sham feeding for testing gastric secretory capacities before and after parietal cell vagotomy.
    Gilly F; Chabal J; Boulez J; Minaire Y
    Br J Surg; 1989 Sep; 76(9):946-8. PubMed ID: 2804593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arhus County Vagotomy Trial: ulcer recurrence rate related to alterations in gastric acid secretion after selective gastric and parietal cell vagotomy.
    Ornsholt J; Amdrup E; Andersen D; Høstrup H
    Scand J Gastroenterol; 1983 May; 18(4):465-72. PubMed ID: 6367013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should it be parietal cell vagotomy or selective vagotomy-antrectomy for treatment of duodenal ulcer? A progress report.
    Jordan PH; Thornby J
    Ann Surg; 1987 May; 205(5):572-90. PubMed ID: 3555364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parietal cell vagotomy and truncal vagotomy in elective duodenal ulcer surgery--results after six to twelve years.
    Elfberg BA; Nilsson F; Selking O
    Ups J Med Sci; 1989; 94(2):129-36. PubMed ID: 2763389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between gastric acid secretion and the rate of recurrent ulcer after parietal cell vagotomy.
    Cohen F; Valleur P; Serra J; Brisset D; Chiche L; Hautefeuille P
    Ann Surg; 1993 Mar; 217(3):253-9. PubMed ID: 8452404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between gastric acid secretion and clinical outcome after parietal cell vagotomy.
    Nylamo EI
    Acta Chir Scand; 1987 Jan; 153(1):33-6. PubMed ID: 3554865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent ulceration after highly selective vagotomy for duodenal ulcer.
    Blackett RL; Johnston D
    Br J Surg; 1981 Oct; 68(10):705-10. PubMed ID: 7025957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gastric functional exploration. Comparison between secretory results in 72 non-ulcer dyspeptic patients and 289 non-operated duodenal ulcer patients. Predictive criteria for the efficacy of fundus vagotomy in duodenal ulcer].
    Vatier J; Poitevin C; Pasquier MC; Vitré MT; Olivier A; Sfedj D; Mignon M
    Gastroenterol Clin Biol; 1991; 15(10):727-34. PubMed ID: 1816013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fundic vagotomy and cholinergic replacement on pentagastrin dose responsive gastric acid and pepsin secretion in man.
    Hirschowitz BI; Helman CA
    Gut; 1982 Aug; 23(8):675-82. PubMed ID: 6807759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parietal cell vagotomy and truncal vagotomy as treatment of duodenal ulcer. A prospective randomized trial.
    Selking O; Krause U; Nilsson F; Thorén L
    Acta Chir Scand; 1981; 147(7):561-7. PubMed ID: 7048827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric acid secretion and its predictive value after vagotomy for perforated duodenal ulcer.
    Koo J; Lam SK; Boey J; Lee NW
    Scand J Gastroenterol; 1983 Oct; 18(7):929-34. PubMed ID: 6374869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.